Inventor · name-matched record
DILILLO DAVID
1 granted patent·2 pending applications·0 citations·filing 2024–2025
13Inventor score
Files withREGENERON PHARMA3
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
3 records- 0177US12590168B2Antigen-binding molecules that bind CD38 and/or CD28, and uses thereofREGENERON PHARMA·Filed 2024·Granted Mar 31, 2026·0 cites·35 claims
- 0267US2026008862A1Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0356US2026014252A1GPRC5D x CD28 Bispecific Antibodies and Methods of Use ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DILILLO DAVID files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →